Literature DB >> 21734579

Cervical cancer treatment in Africa.

Lynette Denny1.   

Abstract

PURPOSE OF REVIEW: This review is to inform the reader about the current situation with regard to treatment of cervical cancer in Africa and the barriers and complexities faced in most African countries. It also reviews the natural history of cervical cancer, the new 2009 International Federation of Gynecology and Obstetrics staging, and current treatment guidelines for cervical cancer. RECENT
FINDINGS: There have been no dramatic new findings in the treatment of cervical cancer other than newer approaches to fertility-sparing surgery and the addition of concomitant chemotherapy to radiation for advanced cervical cancer and the data from randomized trials that have shown an improved overall and disease-free survival. The most important new findings in cervical cancer pertain to cervical cancer prevention strategies, which included using alternative approaches to cytology and the introduction of human papillomavirus (HPV) vaccination.
SUMMARY: Cervical cancer is the commonest cancer cause of death among women in developing countries and efforts to prevent the disease using newer approaches and HPV vaccination should be implemented. Detection of cervical cancer at an early stage is associated with excellent survival but most women in developing countries present with advanced and often untreatable disease. The ratio between incidence and mortality from cervical cancer remains very high, largely due to lack of access to appropriate anticancer therapies in African countries.

Entities:  

Mesh:

Year:  2011        PMID: 21734579     DOI: 10.1097/CCO.0b013e3283495a3f

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  9 in total

1.  A Prospective Investigation of Tumor Hypoxia Imaging with 68Ga-Nitroimidazole PET/CT in Patients with Carcinoma of the Cervix Uteri and Comparison with 18F-FDG PET/CT: Correlation with Immunohistochemistry.

Authors:  Kgomotso M G Mokoala; Ismaheel O Lawal; Letjie C Maserumule; Khanyisile N Hlongwa; Honest Ndlovu; Janet Reed; Meshack Bida; Alex Maes; Christophe van de Wiele; Johncy Mahapane; Cindy Davis; Jae Min Jeong; Gbenga Popoola; Mariza Vorster; Mike M Sathekge
Journal:  J Clin Med       Date:  2022-02-12       Impact factor: 4.241

2.  Prevalence, characteristics, and outcomes of HIV-positive women diagnosed with invasive cancer of the cervix in Kenya.

Authors:  Chemtai Mungo; Craig R Cohen; May Maloba; Elizabeth A Bukusi; Megan J Huchko
Journal:  Int J Gynaecol Obstet       Date:  2013-09-10       Impact factor: 3.561

3.  Screen, Notify, See, and Treat: Initial Results of Cervical Cancer Screening and Treatment in Rwanda.

Authors:  Marie-Aimee Muhimpundu; Fidele Ngabo; Felix Sayinzoga; Jean Paul Balinda; John Rusine; Sardis Harward; Arielle Eagan; Sara Krivacsy; Alice Bayingana; Jean Claude Uwimbabazi; Jean Damascene Makuza; Jean de Dieu Ngirabega; Agnes Binagwaho
Journal:  JCO Glob Oncol       Date:  2021-04

4.  Prevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study.

Authors:  Catherine Ali-Risasi; Kristien Verdonck; Elizaveta Padalko; Davy Vanden Broeck; Marleen Praet
Journal:  Infect Agent Cancer       Date:  2015-07-15       Impact factor: 2.965

5.  A systematic review of radiotherapy capacity in low- and middle-income countries.

Authors:  Surbhi Grover; Melody J Xu; Alyssa Yeager; Lori Rosman; Reinou S Groen; Smita Chackungal; Danielle Rodin; Margaret Mangaali; Sommer Nurkic; Annemarie Fernandes; Lilie L Lin; Gillian Thomas; Ana I Tergas
Journal:  Front Oncol       Date:  2015-01-22       Impact factor: 6.244

6.  Patient Characteristics, Early Outcomes, and Implementation Lessons of Cervical Cancer Treatment Services in Rural Rwanda.

Authors:  Paul H Park; Sonya Davey; Alexandra E Fehr; John Butonzi; Cyprien Shyirambere; Vedaste Hategekimana; Jean Bosco Bigirimana; Ryan Borg; Regis Uwizeye; Neo Tapela; Lawrence N Shulman; Thomas Randall; Egide Mpanumusingo; Tharcisse Mpunga
Journal:  J Glob Oncol       Date:  2018-12

7.  Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer.

Authors:  Tae Wook Kong; Suk-Joon Chang; Jiheum Paek; Seung-Chul Yoo; Jong-Hyuck Yoon; Ki-Hong Chang; Mison Chun; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

Review 8.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.

Authors:  Sarah Finocchario-Kessler; Catherine Wexler; May Maloba; Natabhona Mabachi; Florence Ndikum-Moffor; Elizabeth Bukusi
Journal:  BMC Womens Health       Date:  2016-06-04       Impact factor: 2.809

9.  INVASIVE CERVICAL CANCER IN IBADAN: SOCIO-SEXUAL CHARACTERISTICS, CLINICAL STAGE AT PRESENTATION, HISTOPATHOLOGY DISTRIBUTIONS AND HIV STATUS.

Authors:  Olutosin A Awolude; Sunday O Oyerinde
Journal:  Afr J Infect Dis       Date:  2018-12-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.